SCHEMBL6980011

SCHEMBL6980011

Cc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CCCN2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 4/20 0.58
SLC22A12 Q96S37 2/20 0.46
ALDH1A1 P00352 2/20 0.46
TP53 P04637 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
PKM P14618 4/20 0.45
GSPT1 P15170 1/20 0.44
DDB1 Q16531 1/20 0.44
CRBN Q96SW2 1/20 0.44
LMNA P02545 4/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983095 0.83 BRD4 (0.51) BRD4ALDH1A1PTPN2PTPN1PTPN5
SCHEMBL6984820 0.82 HTR6 (0.61) BRD4ALDH1A1TP53CA12CA1
SCHEMBL6985107 0.80 LMNA (0.67) BRD4ALDH1A1TP53CA12CA1
SCHEMBL6985547 0.80 HTR6 (0.41) BRD4CA12CA1CA2CA9
SCHEMBL6979787 0.79 BRD4 (0.39) BRD4ALDH1A1PKMLMNAMAPT
SCHEMBL11698451 0.79 CA12 (0.54) ALDH1A1TP53TDP1CA12CA1
SCHEMBL31681377 0.78 EIF2AK2 (0.54) BRD4ALDH1A1TP53CA12CA1
SCHEMBL6976538 0.77 PKM (0.65) BRD4ALDH1A1CA12CA1CA2
SCHEMBL13247834 0.76 GSPT1 (0.48) BRD4PKMGSPT1DDB1CRBN
SCHEMBL6985319 0.75 CA12 (0.53) ALDH1A1TP53CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed